EVOKE PHARMA, INC. Dilutive Share Adjustment
EVOKE PHARMA, INC. reported Dilutive Share Adjustment of 53.06 thousand shares for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment · last filed 2018-03-07
- EVOKE PHARMA, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2017-12-31 was 134.62K shares.
- EVOKE PHARMA, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2017-09-30 was 0.00 shares.
- EVOKE PHARMA, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2017-06-30 was 827.07K shares.
- EVOKE PHARMA, INC. weighted average number diluted shares outstanding adjustment for fiscal 2017 was 53.06K shares.
- EVOKE PHARMA, INC. weighted average number diluted shares outstanding adjustment for fiscal 2016 was 0.00 shares.
| Period end | Weighted Average Number Diluted Shares Outstanding Adjustment 3 month | Weighted Average Number Diluted Shares Outstanding Adjustment 6 month | Weighted Average Number Diluted Shares Outstanding Adjustment 9 month | Weighted Average Number Diluted Shares Outstanding Adjustment 12 month |
|---|---|---|---|---|
| 2017-12-31 | 134.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 67.31K shares derived: average of 2 quarters · filed 2018-03-07 | 320.56K shares derived: average of 3 quarters · filed 2018-03-07 | 53.06K shares 10-K · filed 2018-03-07 |
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-11-14 | 413.53K shares derived: average of 2 quarters · filed 2017-11-14 | 25.88K shares 10-Q · filed 2017-11-14 | |
| 2017-06-30 | 827.07K shares 10-Q · filed 2017-08-14 | 413.54K shares 10-Q · filed 2017-08-14 | ||
| 2016-12-31 | 0.00 shares 10-K · filed 2018-03-07 |